pd 98059 and tigapotide

pd 98059 has been researched along with tigapotide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Annabi, B; BĂ©liveau, R; Bouzeghrane, M; Currie, JC; Daigneault, L; Dulude, H; Garde, S; Panchal, C; Rabbani, SA; Wu, JJ1

Other Studies

1 other study(ies) available for pd 98059 and tigapotide

ArticleYear
Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling.
    Anti-cancer drugs, 2006, Volume: 17, Issue:4

    Topics: Antigens, Surface; Bone Neoplasms; Cell Line, Tumor; ELAV Proteins; ELAV-Like Protein 1; Flavonoids; Humans; Laminin; Male; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Oligopeptides; Peptide Fragments; Prostatic Neoplasms; Prostatic Secretory Proteins; Protein Binding; Protein Serine-Threonine Kinases; Receptors, Laminin; RNA-Binding Proteins; Signal Transduction

2006